Ensemble assembles macrocycle pact with Alexion
This article was originally published in Scrip
Executive Summary
Ensemble Therapeutics's drug discovery agreement with Alexion Pharmaceuticals is the Cambridge, Massachusetts-based company's fifth such partnership seeking small molecules from Ensemble's library of 10 million macrocycles to address certain disease targets.